Protective actions of 17 β -Estradiol and progesterone on oxidative neuronal injury induced by organometallic compounds

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Ishihara, Yasuhiro ^a   Takemoto, Takuya ^a   Ishida, Atsuhiko ^a   Yamazaki, Takeshi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCRINOLOGY; HORMONES; LIPIDS; NEURONS; NEUROPHYSIOLOGY; ORGANIC COMPOUNDS; ORGANOMETALLICS;

ANTIOXIDATIVE EFFECTS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEMS; ENDOCRINE GLANDS; ENDOCRINE SYSTEMS; ORGANOMETALLIC COMPOUNDS; PATHOLOGICAL CONDITIONS; PROTECTIVE ACTION;

STEROID HORMONES;

ESTRADIOL; ESTROGEN RECEPTOR; METHYLMERCURY; ORGANOMETALLIC COMPOUND; PROGESTERONE; REACTIVE OXYGEN METABOLITE; TRIBUTYLTIN; OXIDOREDUCTASE;

ANTIOXIDANT ACTIVITY; CENTRAL NERVOUS SYSTEM; GENOMICS; HUMAN; MICROGLIA; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NERVE CELL LESION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; REVIEW; DRUG EFFECTS; GENETICS; INJURIES; METABOLISM;

CENTRAL NERVOUS SYSTEM; ESTRADIOL; HUMANS; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; OXIDOREDUCTASES; PROGESTERONE; REACTIVE OXYGEN SPECIES;

EID: 84925326257     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/343706     Document Type: Review

References (163)

1. J. D. Crapo, T. Oury, C. Rabouille, J.W. Slot, and L.-Y. Chang, "Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 21, pp. 10405-10409, 1992.
2. Y. Kira, E. F. Sato, and M. Inoue, "Association of Cu, Zn-type superoxide dismutase with mitochondria and peroxisomes," Archives of Biochemistry and Biophysics, vol. 399, no. 1, pp. 96-102, 2002.
3. H. Imai and Y. Nakagawa, "Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells," Free Radical Biology and Medicine, vol. 34, no. 2, pp. 145-169, 2003.
4. J. P. Thomas, M. Maiorino, F. Ursini, and A. W. Girotti, "Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation: in situ reduction of phospholipid and cholesterol hydroperoxides," The Journal of Biological Chemistry, vol. 265, no. 1, pp. 454-461, 1990.
5. G. R. Sue, Z. C. Ho, and K. Kim, "Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling," Free Radical Biology and Medicine, vol. 38, no. 12, pp. 1543-1552, 2005.
6. J. M. Matés, "Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology," Toxicology, vol. 153, no. 1-3, pp. 83-104, 2000.
7. E. E. Baulieu, "Neurosteroids: of the nervous system, by the nervous system, for the nervous system," Recent Progress in Hormone Research, vol. 52, pp. 1-32, 1997.
8. K. Wojtal, M. K. Trojnar, and S. J. Czuczwar, "Endogenous neuroprotective factors: neurosteroids," Pharmacological Reports, vol. 58, no. 3, pp. 335-340, 2006.
9. M. Liu, M. H. Kelley, P. S. Herson, and P.D. Hurn, "Neuroprotection of sex steroids," Minerva Endocrinologica, vol. 35, no. 2, pp. 127-143, 2010.
10. A. Faroni and V. Magnaghi, "The neurosteroid allopregnanolone modulates specific functions in central and peripheral glial cells," Frontiers in Endocrinology, vol. 2, article 103, 2011.
11. R. C. Melcangi, G. Panzica, and L. M. Garcia-Segura, "Neuroactive steroids: focus on human brain," Neuroscience, vol. 191, pp. 1-5, 2011.
12. A. M. Traish, H. P. Kang, F. Saad, and A. T. Guay, "Dehydroepiandrosterone (DHEA)-a precursor steroid or an active hormone in human physiology (CME)," Journal of Sexual Medicine, vol. 8, no. 11, pp. 2960-2982, 2011.
13. E. Scott, Q. G. Zhang, R. Wang, R. Vadlamudi, and D. Brann, "Estrogen neuroprotection and the critical period hypothesis," Frontiers in Neuroendocrinology, vol. 33, no. 1, pp. 85-104, 2012.
14. M. Singh and C. Su, "Progesterone and neuroprotection," Hormones and Behavior, vol. 63, no. 2, pp. 284-290, 2013.
15. J. L. Do Rego, J. Y. Seong, D. Burel et al., "Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides," Frontiers in Neuroendocrinology, vol. 30, no. 3, pp. 259-301, 2009.
16. S. Meema, M. L. Bunker, and H. E. Meema, "Preventive effect of estrogen on postmenopausal bone loss," Archives of Internal Medicine, vol. 135, no. 11, pp. 1436-1440, 1975.
17. S. Yusuf and S. Anand, "Hormone replacement therapy: a time for pause," Canadian Medical Association Journal, vol. 167, no. 4, pp. 357-359, 2002.
18. D. B. Dubal, M. L. Kashon, L. C. Pettigrew et al., "Estradiol protects against ischemic injury," Journal of Cerebral Blood Flow and Metabolism, vol. 18, no. 11, pp. 1253-1258, 1998.
19. J.W. Simpkins, P. S. Green, K. E. Gridley, M. Singh, N. C. De Fiebre, and G. Rajakumar, "Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease," American Journal of Medicine, vol. 103, no. 3, pp. 19S-25S, 1997.
20. R. Guevara-Guzmán, V. Arriaga, K. M. Kendrick et al., "Estradiol prevents ozone-induced increases in brain lipid peroxidation and impaired social recognition memory in female rats," Neuroscience, vol. 159, no. 3, pp. 940-950, 2009.
21. L. G. Caceres, S. L. Uran, M. A. Z. Zubilete, J. I. Romero, F. Capani, and L. R. Guelman, "An early treatment with 17-β- estradiol is neuroprotective against the long-term effects of neonatal ionizing radiation exposure," Journal of Neurochemistry, vol. 118, no. 4, pp. 626-635, 2011.
22. A. Ramezani, I. Goudarzi, T. Lashkarbolouki, M. T. Ghorbanian, M. Elahdadi Salmani, and K. Abrari, "Neuroprotective effects of the 17β-estradiol against ethanol-induced neurotoxicity and oxidative stress in the developing male rat cerebellum: biochemical, histological and behavioral changes," Pharmacology Biochemistry and Behavior, vol. 100, no. 1, pp. 144-151, 2011.
23. A. M. Baraka, A. A. Korish, G. A. Soliman, and H. Kamal, "The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease," Life Sciences, vol. 88, no. 19-20, pp. 879-885, 2011.
24. A. K. Rao, A. K. Dietrich, Y. S. Ziegler, and A. M. Nardulli, "17β- Estradiol-mediated increase in Cu/Zn superoxide dismutase expression in the brain: a mechanism to protect neurons from ischemia," The Journal of Steroid Biochemistry and Molecular Biology, vol. 127, no. 3-5, pp. 382-389, 2011.
25. D. Manthey and C. Behl, "From structural biochemistry to expression profiling: neuroprotective activities of estrogen," Neuroscience, vol. 138, no. 3, pp. 845-850, 2006.
26. D. B. Dubal, H. Zhu, J. Yu et al., "Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 4, pp. 1952-1957, 2001.
27. D. B. Dubal, S. W. Rau, P. J. Shughrue et al., "Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death," Endocrinology, vol. 147, no. 6, pp. 3076-3084, 2006.
28. W. Tripanichkul, K. Sripanichkulchai, J. A. Duce, and D. I. Finkelstein, "17Beta-Estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult," Brain Research, vol. 1164, no. 1, pp. 24-31, 2007.
29. W. Dröge, "Free radicals in the physiological control of cell function," Physiological Reviews, vol. 82, no. 1, pp. 47-95, 2002.
30. T. M. Stakhiv, S. Mesia-Vela, and F. C. Kauffman, "Phase II antioxidant enzyme activities in brain of male and female ACI rats treated chronically with estradiol," Brain Research, vol. 1104, no. 1, pp. 80-91, 2006.
31. I. Greeve, I. Hermans-Borgmeyer, C. Brellinger et al., "The humanDIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress," The Journal of Neuroscience, vol. 20, no. 19, pp. 7345-7352, 2000.
32. H. R. Waterham, J. Koster, G. J. Romeijn et al., "Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis," The American Journal of Human Genetics, vol. 69, no. 4, pp. 685-694, 2001.
33. S. Benvenuti, P. Luciani, G. B. Vannelli et al., "Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures," The Journal of Clinical Endocrinology & Metabolism, vol. 90, no. 3, pp. 1775-1782, 2005.
34. P. Luciani, C. Deledda, F. Rosati et al., "Seladin-1 is a fundamentalmediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures," Endocrinology, vol. 149, no. 9, pp. 4256-4266, 2008.
35. T. Burmester, B. Welch, S. Reinhardt, and T. Hankeln, "A verteblrate globin expressed in the brain," Nature, vol. 407, no. 6803, pp. 520-523, 2000.
36. A. Pesce, S. Dewilde, M. Nardini et al., "Human brain neuroglobin structure reveals a distinctmode of controlling oxygen affinity," Structure, vol. 11, no. 9, pp. 1087-1095, 2003.
37. Y. Sun, K. Jin, A. Peel, X. OuMao, L. Xie, and D. A. Greenberg, "Neuroglobin protects the brain from experimental stroke in vivo," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 6, pp. 3497-3500, 2003.
38. E. Fordel, L. Thijs, W. Martinet, D. Schrijvers, L. Moens, and S. Dewilde, "Anoxia or oxygen and glucose deprivation in SHSY5Y cells: a step closer to the unraveling of neuroglobin and cytoglobin functions," Gene, vol. 398, no. 1-2, pp. 114-122, 2007.
39. A. A. Khan, Y. Wang, Y. Sun et al., "Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemia," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 47, pp. 17944-17948, 2006.
40. 2-induced toxicity," Neuro-Signals, vol. 18, no. 4, pp. 223-235, 2010.
41. E. De Marinis, E. Acaz-Fonseca, M. A. Arevalo et al., "17β- Oestradiol anti-inflammatory effects in primary astrocytes require oestrogen receptor β-mediated neuroglobin upregulation," Journal of Neuroendocrinology, vol. 25, no. 3, pp. 260-270, 2013.
42. P. Sur, E. A. Sribnick, J.M. Wingrave, M. W. Nowak, S. K. Ray, and N. L. Banik, "Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells," Brain Research, vol. 971, no. 2, pp. 178-188, 2003.
43. A. L. Mize, R. A. Shapiro, and D. M. Dorsa, "Estrogen receptormediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway," Endocrinology, vol. 144, no. 1, pp. 306-312, 2003.
44. J. L. Fitzpatrick, A. L. Mize, C. B. Wade, J. A. Harris, R. A. Shapiro, and D.M. Dorsa, "Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway," Journal of Neurochemistry, vol. 82, no. 3, pp. 674-682, 2002.
45. Q.-G. Zhang, L. Raz, R. Wang et al., "Estrogen attenuates ischemic oxidative damage via an estrogen receptor α-mediated inhibition of NADPHoxidase activation," The Journal of Neuroscience, vol. 29, no. 44, pp. 13823-13836, 2009.
46. R. A. Quintanilla, F. J. Muñoz, M. J. Metcalfe et al., "Trolox and 17β-estradiol protect against amyloid β-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signaling pathway," The Journal of Biological Chemistry, vol. 280, no. 12, pp. 11615-11625, 2005.
47. A. Boveris, N. Oshino, and B. Chance, "The cellular production of hydrogen peroxide.," Biochemical Journal, vol. 128, no. 3, pp. 617-630, 1972.
48. A. Boveris and B. Chance, "The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen," Biochemical Journal, vol. 134, no. 3, pp. 707-716, 1973.
49. D. Han, E. Williams, and E. Cadenas, "Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space," The Biochemical Journal, vol. 353, part 2, pp. 411-416, 2001.
50. R.W. Irwin, J. Yao, R. T. Hamilton, E. Cadenas, R. D. Brinton, and J. Nilsen, "Progesterone and estrogen regulate oxidative metabolism in brainmitochondria," Endocrinology, vol. 149, no. 6, pp. 3167-3175, 2008.
51. C. Stirone, S. P. Duckles, D. N. Krause, and V. Procaccio, "Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels," Molecular Pharmacology, vol. 68, no. 4, pp. 959-965, 2005.
52. T. T. Jones and G. J. Brewer, "Critical age-related loss of cofactors of neuron cytochrome C oxidase reversed by estrogen," Experimental Neurology, vol. 215, no. 2, pp. 212-219, 2009.
53. A. Razmara, L. Sunday, C. Stirone et al., "Mitochondrial effects of estrogen are mediated by estrogen receptor α in brain endothelial cells," Journal of Pharmacology and Experimental Therapeutics, vol. 325, no. 3, pp. 782-790, 2008.
54. J. Guo, S. P. Duckles, J. H. Weiss, X. Li, and D. N. Krause, "17β- Estradiol prevents cell death and mitochondrial dysfunction by an estrogen receptor-dependent mechanism in astrocytes after oxygen-glucose deprivation/reperfusion," Free Radical Biology & Medicine, vol. 52, no. 11-12, pp. 2151-2160, 2012.
55. S.-H. Yang, R. Liu, E. J. Perez et al., "Mitochondrial localization of estrogen receptor β," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 12, pp. 4130-4135, 2004.
56. S.-H. Yang, S. N. Sarkar, R. Liu et al., "Estrogen receptor beta as a mitochondrial vulnerability factor," The Journal of Biological Chemistry, vol. 284, no. 14, pp. 9540-9548, 2009.
57. J. Long, P. He, Y. Shen, and R. Li, "New evidence of mitochondria dysfunction in the female alzheimer's disease brain: deficiency of estrogen receptor-β," Journal of Alzheimer's Disease, vol. 30, no. 3, pp. 545-558, 2012.
58. C. Behl, T. Skutella, F. Lezoualc'h et al., "Neuroprotection against oxidative stress by estrogens: structure-activity relationship," Molecular Pharmacology, vol. 51, no. 4, pp. 535-541, 1997.
59. B. Moosmann and C. Behl, "The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 16, pp. 8867-8872, 1999.
60. K. Sugioka, Y. Shimosegawa, and M. Nakano, "Estrogens as natural antioxidants of membrane phospholipid peroxidation," FEBS Letters, vol. 210, no. 1, pp. 37-39, 1987.
61. K. Prokai-Tatrai, P. Perjesi, N. M. Rivera-Portalatin, J. W. Simpkins, and L. Prokai, "Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative," Steroids, vol. 73, no. 3, pp. 280-288, 2008.
62. Y. Ishihara, D. Shiba, and N. Shimamoto, "Enhancement of DMNQ-induced hepatocyte toxicity by cytochrome P450 inhibition," Toxicology and Applied Pharmacology, vol. 214, no. 2, pp. 109-117, 2006.
63. S. E. Hickman, E. K. Allison, and J. El Khoury, "Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice," The Journal of Neuroscience, vol. 28, no. 33, pp. 8354-8360, 2008.
64. L. Marinova-Mutafchieva, M. Sadeghian, L. Broom, J. B. Davis, A. D. Medhurst, and D. T. Dexter, "Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease," Journal of Neurochemistry, vol. 110, no. 3, pp. 966-975, 2009.
65. Y.-C. Wang, S. Lin, and Q.-W. Yang, "Toll-like receptors in cerebral ischemic inflammatory injury," Journal of Neuroinflammation, vol. 8, article 134, 2011.
66. S. Najjar, D. M. Pearlman, K. Alper, A. Najjar, and O. Devinsky, "Neuroinflammation and psychiatric illness," Journal of Neuroinflammation, vol. 10, article 43, 2013.
67. D. N. Xanthos and J. Sandkühler, "Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity," Nature Reviews Neuroscience, vol. 15, no. 1, pp. 43-53, 2014.
68. Y. Ishihara, K. Itoh, A. Ishida, and T. Yamazaki, "Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway," The Journal of Steroid Biochemistry and Molecular Biology, vol. 145, pp. 85-93, 2015.
69. E. Vegeto, C. Bonincontro, G. Pollio et al., "Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia," The Journal of Neuroscience, vol. 21, no. 6, pp. 1809-1818, 2001.
70. A. J. Bruce-Keller, J. L. Keeling, J. N. Keller, F. F. Huang, S. Camondola, and M. P. Mattson, "Antiinflammatory effects of estrogen on microglial activation," Endocrinology, vol. 141, no. 10, pp. 3646-3656, 2000.
71. S. Ghisletti, C. Meda, A. Maggi, and E. Vegeto, "17β-estradiol inhibits inflammatory gene expression by controlling NF-κB intracellular localization," Molecular and Cellular Biology, vol. 25, no. 8, pp. 2957-2968, 2005.
72. E. Vegeto, S. Belcredito, S. Etteri et al., "Estrogen receptoralphamediates the brain antiinflammatory activity of estradiol," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9614-9619, 2003.
73. C. M. Brown, T. A. Mulcahey, N. C. Filipek, and P. M. Wise, "Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors α and β," Endocrinology, vol. 151, no. 10, pp. 4916-4925, 2010.
74. K. D. Yi, Z. Y. Cai, D. F. Covey, and J.W. Simpkins, "Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signalregulated kinase 1/2 activation," Journal of Pharmacology and Experimental Therapeutics, vol. 324, no. 3, pp. 1188-1195, 2008.
75. K. D. Yi and J. W. Simpkins, "Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogenmediated neuroprotection," Endocrinology, vol. 149, no. 10, pp. 5235-5243, 2008.
76. G. Lepore, S. Gadau, A. Mura, M. Zedda, and V. Farina, "Aromatase immunoreactivity in fetal ovine neuronal cell cultures exposed to oxidative injury," European Journal of Histochemistry, vol. 53, no. 4, pp. 233-238, 2009.
77. G. Lepore, S. Gadau, A. Peruffo et al., "Aromatase expression in cultured fetal sheep astrocytes after nitrosative/oxidative damage," Cell and Tissue Research, vol. 344, no. 3, pp. 407-413, 2011.
78. M. Liu, P. D. Hurn, C. E. Roselli, and N. J. Alkayed, "Role of P450 aromatase in sex-specific astrocytic cell death," Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 1, pp. 135-141, 2007.
79. A. Miñano, M. A. Cerbón, X. Xifró, C. Malagelada, J. Aguilera, and J. Rodríguez-Alvarez, "17β-estradiol does not protect cerebellar granule cells from excitotoxicity or apoptosis," Journal of Neurochemistry, vol. 102, no. 2, pp. 354-364, 2007.
80. K. B. Gordon, I. M. Macrae, and H. V. O. Carswell, "Effects of 17beta-oestradiol on cerebral ischaemic damage and lipid peroxidation," Brain Research, vol. 1036, no. 1-2, pp. 155-162, 2005.
81. S. M. J. Mohan Kumar, B. S. Kasturi, A. C. Shin et al., "Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia," American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 300, no. 3, pp. R693-R699, 2011.
82. K. Charitidi, I. Meltser, and B. Canlon, "Estradiol treatment and hormonal fluctuations during the estrous cycle modulate the expression of estrogen receptors in the auditory system and the prepulse inhibition of acoustic startle response," Endocrinology, vol. 153, no. 9, pp. 4412-4421, 2012.
83. A. K. Sharma, S. K. Bhattacharya, N. Khanna et al., "Effect of progesterone on phosphamidon-induced impairment of memory and oxidative stress in rats," Human & Experimental Toxicology, vol. 30, no. 10, pp. 1626-1634, 2011.
84. V. H. Ozacmak and H. Sayan, "The effects of 17β estradiol, 17α estradiol and progesterone on oxidative stress biomarkers in ovariectomized female rat brain subjected to global cerebral ischemia," Physiological Research, vol. 58, no. 6, pp. 909-912, 2009.
85. R. Aggarwal, B. Medhi, A. Pathak, V. Dhawan, and A. Chakrabarti, "Neuroprotective effect of progesterone on acute phase changes induced by partial global cerebral ischaemia in mice," The Journal of Pharmacy and Pharmacology, vol. 60, no. 6, pp. 731-737, 2008.
86. K. Moorthy, D. Sharma, S. F. Basir, and N. Z. Baquer, "Administration of estradiol and progesterone modulate the activities of antioxidant enzyme and aminotransferases in naturally menopausal rats," Experimental Gerontology, vol. 40, no. 4, pp. 295-302, 2005.
87. S. B. Pajović, Z. S. Saičić, M. B. Spasić, V. M. Petrović, and J. V. Martinović, "Effects of progesterone and estradiol benzoate on glutathione dependent antioxidant enzyme activities in the brain of female rats," General Physiology and Biophysics, vol. 18, no. 1, pp. 35-44, 1999.
88. J. Kume-Kick and M. E. Rice, "Estrogen-dependent modulation of rat brain ascorbate levels and ischemia-induced ascorbate loss," Brain Research, vol. 803, no. 1-2, pp. 105-113, 1998.
89. R. W. Irwin, J. Yao, S. S. Ahmed, R. T. Hamilton, E. Cadenas, and R. D. Brinton, "Medroxyprogesterone acetate antagonizes estrogen up-regulation of brain mitochondrial function," Endocrinology, vol. 152, no. 2, pp. 556-567, 2011.
90. K. Fent, "Ecotoxicology of organotin compounds," Critical Reviews in Toxicology, vol. 26, no. 1, pp. 1-117, 1996.
91. B. Antizar-Ladislao, "Environmental levels, toxicity and human exposure to tributyltin (TBT)-contaminated marine environment. A review," Environment International, vol. 34, no. 2, pp. 292-308, 2008.
92. T. Tsuda, T. Inoue, M. Kojima, and S. Aoki, "Daily intakes of tributyltin and triphenyltin compounds from meals," Journal of AOAC International, vol. 78, no. 4, pp. 941-943, 1995.
93. M. M. Whalen, B. G. Loganathan, and K. Kannan, "Immunotoxicity of environmentally relevant concentrations of butyltins on human natural killer cells in vitro," Environmental Research, vol. 81, no. 2, pp. 108-116, 1999.
94. K. Kannan, K. Senthilkumar, and J. P. Giesy, "Occurrence of butyltin compounds in human blood," Environmental Science and Technology, vol. 33, no. 10, pp. 1776-1779, 1999.
95. M. Ema, T. Itami, and H. Kawasaki, "Behavioral effects of acute exposure to tributyltin chloride in rats," Neurotoxicology and Teratology, vol. 13, no. 5, pp. 489-493, 1991.
96. M. Ema, T. Itami, and H. Kawasaki, "Changes of spontaneous motor activity of rats after acute exposure to tributyltin chloride," Drug and Chemical Toxicology, vol. 14, no. 1-2, pp. 161-171, 1991.
97. J. P. O'Callaghan and D. B. Miller, "Acute exposure of the neonatal rat to tributyltin results in decreases in biochemical indicators of synaptogenesis and myelinogenesis," Journal of Pharmacology and Experimental Therapeutics, vol. 246, no. 1, pp. 394-402, 1988.
98. J. Yamada, K. Inoue, T. Furukawa, and A. Fukuda, "Lowconcentration tributyltin perturbs inhibitory synaptogenesis and induces neuronal death in immature but not mature neurons," Toxicology Letters, vol. 198, no. 2, pp. 282-288, 2010.
99. S. Mizuhashi, Y. Ikegaya, and N. Matsuki, "Cytotoxicity of tributyltin in rat hippocampal slice cultures," Neuroscience Research, vol. 38, no. 1, pp. 35-42, 2000.
100. R. Kurita, K. Hayashi, K. Torimitsu, and O. Niwa, "Continuous measurement of glutamate and hydrogen peroxide using a microfabricated biosensor for studying the neurotoxicity of tributyltin," Analytical Sciences, vol. 19, no. 12, pp. 1581-1585, 2003.
101. Y. Ishihara, T. Kawami, A. Ishida, and T. Yamazaki, "Tributyltin induces oxidative stress and neuronal injury by inhibiting glutathione S-transferase in rat organotypic hippocampal slice cultures," Neurochemistry International, vol. 60, no. 8, pp. 782-790, 2012.
102. A. Oakley, "Glutathione transferases: a structural perspective," Drug Metabolism Reviews, vol. 43, no. 2, pp. 138-151, 2011.
103. P. Ålin, U. H. Danielson, and B. Mannervik, "4-Hydroxyalk-2-enals are substrates for glutathione transferase," FEBS Letters, vol. 179, no. 2, pp. 267-270, 1985.
104. Q. Guo, S. Y. Qian, and R. P. Mason, "Separation and identification of DMPO adducts of oxygen-centered radicals formed from organic hydroperoxides by HPLC-ESR, ESI-MS and MS/MS," Journal of the American Society for Mass Spectrometry, vol. 14, no. 8, pp. 862-871, 2003.
105. J. Klimek, M. Woźniak, G. Szymańska, and L. Zelewski, "Inhibitory effect of free radicals derived from organic hydroperoxide on progesterone synthesis in human term placental mitochondria," Free Radical Biology and Medicine, vol. 24, no. 7-8, pp. 1168-1175, 1998.
106. 2 and impaired cytokine pattern in cultured keratinocytes and blood of vitiligo patients," Antioxidants and Redox Signaling, vol. 13, no. 5, pp. 607-620, 2010.
107. K. Uchida, M. Shiraishi, Y. Naito, Y. Torii, Y. Nakamura, and T. Osawa, "Activation of stress signaling pathways by the end product of lipid peroxidation: 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production," The Journal of Biological Chemistry, vol. 274, no. 4, pp. 2234-2242, 1999.
108. S. Baez, J. Segura-Aguilar, M. Widersten, A.-S. Johansson, and B. Mannervik, "Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes," The Biochemical Journal, vol. 324, no. 1, pp. 25-28, 1997.
109. A. Dagnino-Subiabre, B. K. Cassels, S. Baez, A.-S. Johansson, B. Mannervik, and J. Segura-Aguilar, "Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones," Biochemical and Biophysical Research Communications, vol. 274, no. 1, pp. 32-36, 2000.
110. S. Kawato, M. Yamada, and T. Kimoto, "Brain neurosteroids are 4th generation neuromessengers in the brain: cell biophysical analysis of steroid signal transduction," Advances in Biophysics, vol. 37, pp. 1-48, 2003.
111. Y. Ishihara, N. Fujitani, T. Kawami, C. Adachi, A. Ishida, and T. Yamazaki, "Suppressive effects of 17β-estradiol on tributyltininduced neuronal injury via Akt activation and subsequent attenuation of oxidative stress," Life Sciences, vol. 99, no. 1-2, pp. 24-30, 2014.
112. D. B. Zorov, M. Juhaszova, and S. J. Sollott, "Mitochondrial ROS-induced ROS release: an update and review," Biochimica et Biophysica Acta: Bioenergetics, vol. 1757, no. 5-6, pp. 509-517, 2006.
113. A. Vasconsuelo, L. Milanesi, and R. Boland, "17β-estradiol abrogates apoptosis inmurine skeletalmuscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway," Journal of Endocrinology, vol. 196, no. 2, pp. 385-397, 2008.
114. E. Röth, N. Marczin, B. Balatonyi et al., "Effect of a glutathione S-transferase inhibitor on oxidative stress and ischemia reperfusion-induced apoptotic signalling of cultured cardiomyocytes," Experimental and Clinical Cardiology, vol. 16, no. 3, pp. 92-96, 2011.
115. Y. Ishihara, T. Kawami, A. Ishida, and T. Yamazaki, "Allopregnanolone-mediated protective effects of progesterone on tributyltin-induced neuronal injury in rat hippocampal slices," The Journal of Steroid Biochemistry and Molecular Biology, vol. 135, no. 1, pp. 1-6, 2013.
116. A receptor," Nature Reviews Neuroscience, vol. 6, no. 7, pp. 565-575, 2005.
117. A. Ardeshiri, M. H. Kelley, I. P. Korner, P. D. Hurn, and P. S. Herson, "Mechanism of progesterone neuroprotection of rat cerebellar Purkinje cells following oxygen-glucose deprivation," The European Journal of Neuroscience, vol. 24, no. 9, pp. 2567-2574, 2006.
118. Y. Nakatsu, Y. Kotake, K. Komasaka et al., "Glutamate excitotoxicity is involved in cell death caused by tributyltin in cultured rat cortical neurons," Toxicological Sciences, vol. 89, no. 1, pp. 235-242, 2006.
119. A receptor with muscimol reduces amyloid β protein (25-35)-induced neurotoxicity in cultured rat cortical cells," Neuroscience Research, vol. 52, no. 4, pp. 347-356, 2005.
120. M. Aschner and T. Syversen, "Methylmercury: recent advances in the understanding of its neurotoxicity," Therapeutic Drug Monitoring, vol. 27, no. 3, pp. 278-283, 2005.
121. T.W. Clarkson, "The toxicology ofmercury," Critical Reviews in Clinical Laboratory Sciences, vol. 34, no. 4, pp. 369-403, 1997.
122. K. Eto, "Minamata disease," Neuropathology, vol. 20, supplement, pp. S14-S19, 2000.
123. T. Takeuchi, "Pathology of Minamata disease. With special reference to its pathogenesis," Acta Pathologica Japonica, vol. 32, supplement 1, pp. 73-99, 1982.
124. F. Bakir, S. F. Damluji, I. Amin-Zaki et al., "Methylmercury poisoning in Iraq," Science, vol. 181, no. 4096, pp. 230-241, 1973.
125. M. Aschner and T. W. Clarkson, "Uptake of methylmercury in the rat brain: effects of amino acids," Brain Research, vol. 462, no. 1, pp. 31-39, 1988.
126. M. Aschner and T.W. Clarkson, "Methylmercury uptake across bovine brain capillary endothelial cells in vitro: the role of amino acids," Pharmacology and Toxicology, vol. 64, no. 3, pp. 293-297, 1989.
127. M. Uchino, T. Okajima, K. Eto, T. Kumamoto, I. Mishima, and M. Ando, "Neurologic features of chronic Minamata disease (organic mercury poisoning) certified at autopsy," Internal Medicine, vol. 34, no. 8, pp. 744-747, 1995.
128. S. M. Charbonneau, I. C. Munro, E. A. Nera et al., "Subacute toxicity of methylmercury in the adult cat," Toxicology and Applied Pharmacology, vol. 27, no. 3, pp. 569-581, 1974.
129. Y. Ikeda, M. Tobe, K. Kobayashi, S. Suzuki, Y. Kawasaka, and H. Yonemaru, "Long-term toxicity study of methylmercuric chloride in monkeys (first report)," Toxicology, vol. 1, no. 4, pp. 361-375, 1973.
130. R. Klein, S. P. Herman, P. E. Brubaker, G. W. Lucier, and M. R. Krigman, "A model of acute methyl mercury intoxication in rats," Archives of Pathology, vol. 93, no. 5, pp. 408-418, 1972.
131. M. Farina, M. Aschner, and J. B. T. Rocha, "Oxidative stress in MeHg-induced neurotoxicity," Toxicology and Applied Pharmacology, vol. 256, no. 3, pp. 405-417, 2011.
132. Y. Tsuzuki and T. Yamada, "Inhibitory actions of mercury compounds against glucose-6-phosphate dehydrogenase from yeast," Journal of Toxicological Sciences, vol. 4, no. 2, pp. 105-113, 1979.
133. V. Glaser, G. Leipnitz, M. R. Straliotto et al., "Oxidative stressmediated inhibition of brain creatine kinase activity by methylmercury," Neuro Toxicology, vol. 31, no. 5, pp. 454-460, 2010.
134. J. Stringari, A. K. C. Nunes, J. L. Franco et al., "Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain," Toxicology and Applied Pharmacology, vol. 227, no. 1, pp. 147-154, 2008.
135. J. L. Franco, T. Posser, P. R. Dunkley et al., "Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase," Free Radical Biology & Medicine, vol. 47, no. 4, pp. 449-457, 2009.
136. V. Branco, J. Canário, A. Holmgren, and C. Carvalho, "Inhibition of the thioredoxin system in the brain and liver of zebraseabreams exposed to waterborne methylmercury," Toxicology and Applied Pharmacology, vol. 251, no. 2, pp. 95-103, 2011.
137. M. Farina, F. Campos, I. Vendrell et al., "Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells," Toxicological Sciences, vol. 112, no. 2, pp. 416-426, 2009.
138. F. Usuki, A. Yamashita, and M. Fujimura, "Post-transcriptional defects of antioxidant selenoenzymes cause oxidative stress under methylmercury exposure," Journal of Biological Chemistry, vol. 286, no. 8, pp. 6641-6649, 2011.
139. D. Grotto, M. M. de Castro, G. R. M. Barcelos, S. C. Garcia, and F. Barbosa Jr., "Low level and sub-chronic exposure to methylmercury induces hypertension in rats: nitric oxide depletion and oxidative damage as possiblemechanisms," Archives of Toxicology, vol. 83, no. 7, pp. 653-662, 2009.
140. A. S. de Freitas, V. R. Funck, M. D. S. Rotta et al., "Diphenyl diselenide, a simple organoselenium compound, decreases methylmercury-induced cerebral, hepatic and renal oxidative stress and mercury deposition in adult mice," Brain Research Bulletin, vol. 79, no. 1, pp. 77-84, 2009.
141. N. Mori, A. Yasutake, and K. Hirayama, "Comparative study of activities in reactive oxygen species production/defense system in mitochondria of rat brain and liver, and their susceptibility to methylmercury toxicity," Archives of Toxicology, vol. 81, no. 11, pp. 769-776, 2007.
142. 2 and methylmercury in astrocytes: selectivity and reversibility," Journal of Neurochemistry, vol. 53, no. 4, pp. 1228-1237, 1989.
143. M. Aschner, C. P. Yao, J. W. Allen, and K. H. Tan, "Methylmercury alters glutamate transport in astrocytes," Neurochemistry International, vol. 37, no. 2-3, pp. 199-206, 2000.
144. L. O. Porciúncula, J. B. T. Rocha, R. G. Tavares, G. Ghisleni, M. Reis, and D. O. Souza, "Methylmercury inhibits glutamate uptake by synaptic vesicles from rat brain," Neuro Report, vol. 14, no. 4, pp. 577-580, 2003.
145. 2+," Toxicology, vol. 214, no. 1-2, pp. 57-66, 2005.
146. J. N. Reynolds and W. J. Racz, "Effects of methylmercury on the spontaneous and potassium-evoked release of endogenous amino acids from mouse cerebellar slices," Canadian Journal of Physiology and Pharmacology, vol. 65, no. 5, pp. 791-798, 1987.
147. I. Vendrell, M. Carrascal, M.-T. Vilaró, J. Abián, E. Rodríguez-Farré, and C. Suñol, "Cell viability and proteomic analysis in cultured neurons exposed to methylmercury," Human & Experimental Toxicology, vol. 26, no. 4, pp. 263-272, 2007.
148. B. I. Juárez, M. L. Martínez, M. Montante, L. Dufour, E. García, and M. E. Jiménez-Capdeville, "Methylmercury increases glutamate extracellular levels in frontal cortex of awake rats," Neurotoxicology and Teratology, vol. 24, no. 6, pp. 767-771, 2002.
149. H. E. Ganther, "Modification of methylmercury toxicity and metabolism by selenium and vitamin E: possible mechanisms," Environmental Health Perspectives, vol. 25, pp. 71-76, 1978.
150. L. W. Chang, M. Gilbert, and J. Sprecher, "Modification of methylmercury neurotoxicity by vitamin E," Environmental Research, vol. 17, no. 3, pp. 356-366, 1978.
151. P. Beyrouty and H.M. Chan, "Co-consumption of seleniumand vitamin E altered the reproductive and developmental toxicity of methylmercury in rats," Neurotoxicology and Teratology, vol. 28, no. 1, pp. 49-58, 2006.
152. K. N. Prasad and S. Ramanujam, "Vitamin E and vitamin C alter the effect of methylmercuric chloride on neuroblastoma and glioma cells in culture," Environmental Research, vol. 21, no. 2, pp. 343-349, 1980.
153. A. K. West, J. Hidalgo, D. Eddins, E. D. Levin, and M. Aschner, "Metallothionein in the central nervous system: roles in protection, regeneration and cognition," Neurotoxicology, vol. 29, no. 3, pp. 489-503, 2008.
154. P. Zhang, Y. Xu, L. Li, Q. Jiang, M. Wang, and L. Jiñ, "In vitro protective effects of pyrroloquinoline quinone on methylmercury-induced neurotoxicity," Environmental Toxicology and Pharmacology, vol. 27, no. 1, pp. 103-110, 2009.
155. M. Sakaue, N. Mori, M. Okazaki et al., "Vitamin K has the potential to protect neurons from methylmercury-induced cell death in vitro," Journal of Neuroscience Research, vol. 89, no. 7, pp. 1052-1058, 2011.
156. Y. Kumagai, H. Kanda, Y. Shinkai, and T. Toyama, "The role of the Keap1/Nrf2 pathway in the cellular response to methylmercury," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 848279, 8 pages, 2013.
157. E. Daré, M. E. Götz, B. Zhivotovsky, L. Manzo, and S. Ceccatelli, "Antioxidants J811 and 17β-estradiol protect cerebellar granule cells from methylmercury-induced apoptotic cell death," Journal of Neuroscience Research, vol. 62, no. 4, pp. 557-565, 2000.
158. K. S. Malagutti, A. P. da Silva, H. C. Braga et al., "17β-estradiol decreases methylmercury-induced neurotoxicity inmale mice," Environmental Toxicology and Pharmacology, vol. 27, no. 2, pp. 293-297, 2009.
159. E. Munetsuna, Y. Hojo, M. Hattori et al., "Retinoic acid stimulates 17β-estradiol and testosterone synthesis in rat hippocampal slice cultures," Endocrinology, vol. 150, no. 9, pp. 4260-4269, 2009.
160. T. Yamazaki, M. Yamamoto, Y. Ishihara et al., "De novo synthesized estradiol protects against methylmercury-induced neurotoxicity in cultured rat hippocampal slices," PLoS ONE, vol. 8, no. 2, Article ID e55559, 2013.
161. C. S. Chetty, M. C. Vemuri, G. R. Reddy, and C. Suresh, "Protective effect of 17-β-estradiol in human neurocellular models of lead exposure," Neuro Toxicology, vol. 28, no. 2, pp. 396-401, 2007.
162. A. T. M. Konkle and M. M. McCarthy, "Developmental time course of estradiol, testosterone, and dihydrotestosterone levels in discrete regions ofmale and female rat brain," Endocrinology, vol. 152, no. 1, pp. 223-235, 2011.
163. S. K. Amateau, J. J. Alt, C. L. Stamps, and M. M. McCarthy, "Brain estradiol content in newborn rats: Sex differences, regional heterogeneity, and possible de novo synthesis by the female telencephalon," Endocrinology, vol. 145, no. 6, pp. 2906-2917, 2004.